lilly tirzepatide approval Diabetes drug resolves sleep apnea in up to 52% of patients—is FDA in the cards? F.D.A. Approves New Obesity Drug

The new Eli Lilly pill is orforglipron, an oral GLP-1 medication designed to support weight loss and improve blood sugar

CT has a better spatial resolution than MRI, but it cannot effectively distinguish smaller aldosterone-producing adenomas or identify functional differences in aldosterone secretion between the adrenal glands

"As much as 40% of people using these drugs give up after the first month." A second hormone released after eating is glucose-dependent insulinotropic peptide (GIP)

Entertainment journalism often relies on dramatic contrasts, yet in this case, writers highlighted how Mindy Kaling Weight Loss aligned with her evolving lifestyle and professional rhythm

GLP-1 receptor agonists like Ozempic may actually have anti-inflammatory effects, which could be beneficial for people with conditions like osteoarthritis